New York bills · 2025 Regular Session
New York A 3236
Enacts the "New York affordable drug manufacturing act"
- Introduced
- In committee
- Passed House
- Passed Senate
- To Governor
- Became law
Sponsors
- Jenifer Rajkumar (Democratic)
Cosponsors (11)
- Linda Rosenthal (Democratic)
- Rebecca Seawright (Democratic)
- William Colton (Democratic)
- Angelo Santabarbara (Democratic)
- Jo Anne Simon (Democratic)
- Judy Griffin (Democratic)
- Phara Souffrant Forrest (Democratic)
- Phil Steck (Democratic)
- Jeffrey Dinowitz (Democratic)
- Steve Stern (Democratic)
- Jessica Gonzalez-Rojas (Democratic/Working Families)
Summary
Official abstract published by the New York legislature
Enacts the "New York affordable drug manufacturing act" to direct the commissioner of health to enter into partnerships to increase competition, lower prices, and address shortages in the market for generic prescription drugs, to reduce the cost of prescription drugs for public and private purchasers, taxpayers, and consumers, and to increase patient access to affordable drugs.
Text versions
Roll-call votes
No recorded votes on this bill.
Actions
- Jan 7, 2026 · House
REFERRED TO HEALTH - Jan 27, 2025 · House
REFERRED TO HEALTH